Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the safety of irinotecan and cisplatin in combination
with either capecitabine or continuous infusion 5-fluorouracil and to see what effects (good
and bad) these have on patients with unresectable, advanced solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Brigham and Women's Hospital Massachusetts General Hospital